The article, “Ex-Vivo Normothermic Limb Perfusion With a Hemoglobin-Based Oxygen Carrier (HBOC) Perfusate,” that was published on February 19, 2020 contained an error.
The fifth author Dr S. Dasarathy would like to declare his funding sources. The funding sources are National Institutes of Health (R21 AA022742, RO1 DK 113196, RO1 GM119174, R56HL141744, P50 AA024333, UO1 AA021890, UO1 AA026975, and UO1 DK061732) and the Mikati Foundation Grant support.
The authors regret this error.
Reference
1. Said SA, Ordeñana CX, Rezaei M et al: Ex-vivo normothermic limb perfusion with a hemoglobin-based oxygen carrier perfusate. Mil Med 2020; 185(Supplement_1): 110–20.
Presented as a poster at the 2018 Military Health System Research Symposium, August 2018, Kissimmee, FL; abstract # MHSRS-18-1264
There are no conflict of interests to disclose. HBOC-201 was donated by Hemoglobin Oxygen Therapeutics LLC., Home Souderton, PA, USA.